New Zealand vs Norway: Pharmaceutical consumption
Pharmaceutical consumption over time
- New Zealand
- Norway
How they compare
New Zealand currently reports 351.1 Defined daily dose per 1 000 inhabitants per day against 342.2 Defined daily dose per 1 000 inhabitants per day in Norway, a difference of 8.9 Defined daily dose per 1 000 inhabitants per day.
Across all 8 years both countries report, New Zealand has been ahead every year.
New Zealand ranks 7th and Norway ranks 8th of 21 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 348.5 Defined daily dose per 1 000 inhabitants per day | 269.2 Defined daily dose per 1 000 inhabitants per day | 79.3 Defined daily dose per 1 000 inhabitants per day | New Zealand |
| 2020s | 343.83 Defined daily dose per 1 000 inhabitants per day | 306.98 Defined daily dose per 1 000 inhabitants per day | 36.85 Defined daily dose per 1 000 inhabitants per day | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pharmaceutical consumption, New Zealand or Norway?
- New Zealand, at 351.1 Defined daily dose per 1 000 inhabitants per day against 342.2 Defined daily dose per 1 000 inhabitants per day in Norway as of 2025.
- What is the difference in pharmaceutical consumption between New Zealand and Norway?
- 8.9 Defined daily dose per 1 000 inhabitants per day, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Norway?
- 8 years are reported by both, from 2018 to 2025.
- How do New Zealand and Norway rank globally for pharmaceutical consumption?
- New Zealand ranks 7th and Norway ranks 8th of 21 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.